| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/18/2001 | WO2001003657A1 Topically applied idebenone-containing agent with protective and regenerative effect |
| 01/18/2001 | WO2001003648A2 Oregano-based therapeutic composition |
| 01/18/2001 | DE19932197A1 Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung Topically applied agents with protective and regenerative effect |
| 01/17/2001 | EP1068869A2 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 01/17/2001 | EP0862446B1 Herbal-based oral composition and process for producing the same |
| 01/17/2001 | CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase |
| 01/17/2001 | CN1280499A Use of ginkgo biloba extracts for preparing a medicine |
| 01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/16/2001 | US6174560 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 01/16/2001 | US6174516 Method to enhance peroxide tooth whitening |
| 01/16/2001 | CA2223404C Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt |
| 01/16/2001 | CA2188793C Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 01/16/2001 | CA2140345C Anti-inflammatory compounds for ophthalmic use |
| 01/11/2001 | WO2001002578A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones |
| 01/10/2001 | EP1066828A1 Medicaments |
| 01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
| 01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279600A Conditioning shampoo composition comprising pantaerythritol ester oil |
| 01/10/2001 | CN1279060A Anhidrotic emulsion containing fine aluminum and zirconium powders, and preparing method thereof |
| 01/10/2001 | CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/04/2001 | WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 01/04/2001 | WO1999062451A8 Topical transdermal treatments |
| 01/03/2001 | EP1064967A2 5HT1 receptor agonists, caffeine and either a COX-2 inhibitor or NSAID for the treatment of migraine |
| 01/03/2001 | EP1064966A2 Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine |
| 01/03/2001 | EP1064948A2 Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine |
| 01/03/2001 | EP1064946A2 Topical zinc compositions |
| 01/03/2001 | EP1063998A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/03/2001 | EP1063995A1 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator |
| 01/03/2001 | CN1278830A Ultra-fine microcrystalline cellulose compositions and process for their manufacture |
| 01/03/2001 | CN1278722A 8a-azalides as veterinary antimicrobial agents for animals |
| 01/03/2001 | CN1278719A Cleansing compositions |
| 01/03/2001 | CN1278718A Conditioning shampoo composition comprising pentaerythritol ester oil |
| 01/02/2001 | US6168794 Compositions comprising oleum Melaleuca |
| 01/02/2001 | CA2148571C Sunscreen compositions |
| 01/02/2001 | CA2122304C Transparent clear cosmetic stick composition containing sodium salts of methyl carboxyl derivatives of ethoxylated lauryl alcohol |
| 12/30/2000 | CA2312989A1 Combination therapy for the treatment of migraine |
| 12/30/2000 | CA2312633A1 Combination therapy for the treatment of migraine |
| 12/30/2000 | CA2312631A1 5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine |
| 12/28/2000 | WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | WO2000078127A1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 12/28/2000 | CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions |
| 12/28/2000 | CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/27/2000 | EP1062264A2 Enzyme inhibitors |
| 12/27/2000 | EP1062201A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 12/27/2000 | EP1061928A2 New contraceptive kit |
| 12/27/2000 | EP1061901A1 Nicotine inhaler |
| 12/27/2000 | EP1061894A1 Fragrance enhancing compositions for cosmetic products |
| 12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 12/27/2000 | CN1278178A Use of macrolies for treating cancer and macular degeneration |
| 12/27/2000 | CN1059902C Estrogen excitant/antagonist |
| 12/26/2000 | US6166025 A stable, aqueous drug formulation for treating migraine |
| 12/26/2000 | US6165447 Synergistic combination of about 0.003 to about 2.0% by weight triclosan and about 0.003 to about 2.0% by weight of a mixture of hexahydrocolupulone and hexahydrolupulone. |
| 12/26/2000 | CA2150671C Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 12/21/2000 | WO2000077000A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | WO2000076999A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | WO2000076998A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | WO2000076997A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | WO2000076961A1 Inhibitors of aspartyl protease |
| 12/21/2000 | WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 12/21/2000 | WO2000076470A1 Synergistic antibacterial combination |
| 12/21/2000 | WO2000050047A3 Composition for the treatment of psoriasis |
| 12/21/2000 | CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 12/21/2000 | CA2384339A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | CA2377395A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | CA2377325A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/21/2000 | CA2376851A1 Synergistic antibacterial combination |
| 12/21/2000 | CA2375841A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 12/20/2000 | EP1059934A2 Matrix protein compositions for wound healing |
| 12/20/2000 | EP0817608B1 Liquid cleanser compositions |
| 12/19/2000 | US6162774 Mixture of salicylic acid, maleic acid and pyruvic acid with detergent base |
| 12/19/2000 | CA2028629C Antiandrogenically-effective pharmaceutical compositions |
| 12/14/2000 | WO2000074695A2 Tanacetum parthenium extract |
| 12/14/2000 | WO2000044763A3 Compositions for treating inflammatory response |
| 12/13/2000 | EP1058537A1 Personal hygiene product with enhanced fragrance delivery |
| 12/13/2000 | EP1058536A1 Compositions with low irritancy |
| 12/13/2000 | EP1058533A1 High moisture toothpaste |
| 12/13/2000 | CN1276726A Method for treating hypercoagulable states or acquired protein C deficiency |
| 12/13/2000 | CN1276370A Process for preparing anticancer compound, and intermediate |
| 12/13/2000 | CN1276205A Turmeric as antiirritant in composition contg. hydroxy acid or retinene derivs. |
| 12/12/2000 | US6159952 Bronchodilator agents |
| 12/12/2000 | US6159446 Mixture of binder, water, polishing agent, humectant and surfactant |
| 12/09/2000 | CA2308691A1 Live attenuated bacteria for use in a vaccine |
| 12/07/2000 | WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
| 12/07/2000 | WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin |
| 12/07/2000 | WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
| 12/07/2000 | WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 12/07/2000 | CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
| 12/07/2000 | CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
| 12/06/2000 | EP1057473A1 Finely particulated aluminium and zirconium containing antiperspirant suspensions with improved activity and process for their preparation |
| 12/06/2000 | EP1056759A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 12/05/2000 | US6156881 Inhibition of cell adhesion protein-carbohydrate interactions |